8 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
per patient as well as critical raw
materials and process intermediates to facilitate a robust analytical characterization program, with a variety … of a generic medicinal product, for example, because of differences in raw materials or manufacturing processes. For such products, the results of appropriate
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
as well as critical raw materials and process intermediates to facilitate a robust analytical characterization program, with a variety of functional … medicinal product but that do not meet the definition of a generic medicinal product, for example, because of differences in raw materials or manufacturing
S-1/A
TSBX
Turnstone Biologics Corp
23 Jun 23
IPO registration (amended)
9:49pm
strategy for the final TIL product manufactured per patient as well as critical raw materials and process intermediates to facilitate a robust … , for example, because of differences in raw materials or manufacturing processes. For such products, the results of appropriate preclinical or clinical
S-1
TSBX
Turnstone Biologics Corp
12 Jun 23
IPO registration
4:28pm
as critical raw materials and process intermediates to facilitate a robust analytical characterization program, with a variety of functional and phenotypic … that are similar to a reference medicinal product but that do not meet the definition of a generic medicinal product, for example, because of differences in raw
S-1
EX-10.8
4byru
12 Jun 23
IPO registration
4:28pm
DRS
EX-10.8
kh53 ynzbdd
15 May 23
Draft registration statement
12:00am
DRS
owqa3fx
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next